Your browser doesn't support javascript.
loading
Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.
Backus, L I; Belperio, P S; Shahoumian, T A; Loomis, T P; Mole, L A.
Affiliation
  • Backus LI; Department of Veterans Affairs, Population Health Services, Palo Alto Health Care System, Palo Alto, CA, USA.
  • Belperio PS; Department of Veterans Affairs, Population Health Services, Palo Alto Health Care System, Palo Alto, CA, USA.
  • Shahoumian TA; Department of Veterans Affairs, Population Health Services, Palo Alto Health Care System, Palo Alto, CA, USA.
  • Loomis TP; Department of Veterans Affairs, Population Health Services, Palo Alto Health Care System, Palo Alto, CA, USA.
  • Mole LA; Department of Veterans Affairs, Population Health Services, Palo Alto Health Care System, Palo Alto, CA, USA.
Aliment Pharmacol Ther ; 44(4): 400-10, 2016 08.
Article in En | MEDLINE | ID: mdl-27291852

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis C, Chronic Type of study: Evaluation_studies / Observational_studies / Prognostic_studies Limits: Aged80 Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis C, Chronic Type of study: Evaluation_studies / Observational_studies / Prognostic_studies Limits: Aged80 Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom